MID1–PP2A complex functions as new insights in human lung adenocarcinoma

  • Lin Zhang
  • Junyao Li
  • Xuejiao Lv
  • Tingting Guo
  • Wei Li
  • Jie Zhang
Original Article – Cancer Research



MID1 is an E3 ubiquitin ligase that was first found in Opitz G/BBB syndrome, but there has been little research into its role in lung diseases. We have found an accumulating evidence that indicates the MID1–PP2A complex plays a role in asthma and contributes to inflammation, but its roles in lung adenocarcinoma are unclear. This study aimed at evaluating the function of MID1–PP2A complex in human lung adenocarcinoma.


We used western blot, ELISA and real-time quantitative PCR to detect the protein and mRNA levels of MID1 and PP2A in A549, H1975, and H1650 lung adenocarcinoma cell lines compared with the human bronchial epithelial cell line BEAS-2B. Additionally, we used IHC, ELISA and real-time quantitative PCR to dectect MID1 and PP2A levels in 30-paired lung adenocarcinoma tissues. We also detected apoptosis, proliferation and cell cycle-related protein expression after silencing MID1 and activing PP2A.


Our data show that MID1 was significantly upregulated in 30-paired lung adenocarcinoma tissues, and in A549, H1975 and H1650 cell lines compared with BEAS-2B. PP2A showed the opposite results. Furthermore, both upregulated MID1 and downregulated PP2A were correlated with age, but not sex, TNM stage or smoking history. In vitro experiments showed that PP2A was upregulated in lung adenocarcinoma cell lines that were transfected with MID1-siRNA, suggesting MID1 negatively regulates PP2A in lung adenocarcinoma. We also found that silencing MID1 expression or activating PP2A induced apoptosis, proliferation and cell cycle arrest.


We demonstrated that the MID1–PP2A complex plays an important role in lung adenocarcinoma, influencing cell cycle progression, proliferation and apoptosis. Our findings showed a novel molecular mechanism of lung tumorigenesis that may provide new insights for anti-tumor therapies.


MID1 PP2A Lung adenocarcinoma Apoptosis Cell cycle Proliferation 



The authors wish to thank the Second Affiliated Hospital of Jilin University, as well as the patients and their families.

Author contributions

JZ contributed to the conception of the study. JL, XL, TG and WL contributed significantly to analysis and manuscript preparation; LZ finished the experiments, performed the data analyses and wrote the manuscript.


This study was funded by the National Natural Science Foundation of China (number: 81472169, 8167101845).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. Aranda-Orgilles B et al (2008) The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex. Hum Genet 123:163–176. CrossRefPubMedPubMedCentralGoogle Scholar
  2. Arigoni M et al (2013) miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas through Suppression of MIDI. and MTCH2. Am J Pathol 182:2058–2070. CrossRefPubMedGoogle Scholar
  3. Bishop JM (1991) Mol Themes Oncog Cell 64:235–248Google Scholar
  4. Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy senescence FEBS J 277:2–21. CrossRefPubMedGoogle Scholar
  5. Chen J, Hu R, Zhu Y, Shen G, Zhang H (2014) Arabidopsis PHOSPHOTYROSYL PHOSPHATASE ACTIVATOR is essential for PROTEIN PHOSPHATASE 2A holoenzyme assembly and plays important roles in hormone signaling, salt stress response, and plant development. Plant Physiol 166:1519–1534. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Collison A et al (2013) The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nature Med 19:232–237. CrossRefPubMedGoogle Scholar
  7. Collison A et al (2014) Tumor necrosis factor–related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease American. J Respir Cell Mol Biol 51:86–93. CrossRefGoogle Scholar
  8. Cristobal I et al (2014) PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential. Mol Cancer Therapeutics 13:938–947. CrossRefGoogle Scholar
  9. Cristobal I et al (2015) Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer Clin Cancer Res 21:347–356. CrossRefPubMedGoogle Scholar
  10. Demir U, Koehler A, Schneider R, Schweiger S, Klocker H (2014) Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. BMC Cancer 14:52. CrossRefPubMedPubMedCentralGoogle Scholar
  11. Grech G et al (2016a) Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options Tumour Biol 37:11691–11700. CrossRefPubMedGoogle Scholar
  12. Grech G et al (2016b) Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options. Tumor Biol 37:11691–11700. CrossRefGoogle Scholar
  13. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation and cancer Cell 140:883–899. CrossRefPubMedPubMedCentralGoogle Scholar
  14. Hao JM et al (2010) A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol 220:475–489. PubMedGoogle Scholar
  15. Kloeker S et al. (2003) Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein Protein Expr Purif 31:19–33CrossRefPubMedGoogle Scholar
  16. Kohler A et al. (2014) A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling Molecular. Cancer 13:146 Google Scholar
  17. Krauss S, Foerster J, Schneider R, Schweiger S (2008) Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI. 3 Cancer Res 68:4658–4665. CrossRefGoogle Scholar
  18. Krauß S et al (2013) Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1–PP2A protein complex. Nat Commun 4:1511. CrossRefPubMedGoogle Scholar
  19. Li J, Yang M, Li P, Su Z, Gao P, Zhang J (2014) Idiopathic pulmonary fibrosis will increase the risk of lung cancer. Chinese Med J 127:3142–3149Google Scholar
  20. Liu E, Knutzen CA, Krauss S, Schweiger S, Chiang GG (2011) Control of mTORC1 signaling by the Opitz syndrome protein MID1 Proc Natl Acad Sci USA 108:8680–8685. CrossRefPubMedPubMedCentralGoogle Scholar
  21. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079PubMedGoogle Scholar
  22. Lv XJ, Du YW, Hao YQ, Su ZZ, Zhang L, Zhao LJ, Zhang J (2016) RNA-binding motif protein 5 inhibits the proliferation of cigarette smoke-transformed BEAS-2B cells through cell cycle arrest and apoptosis Oncol Rep 35:2315–2327. CrossRefPubMedGoogle Scholar
  23. Mane DR, Kale AD, Belaldavar C (2017) Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: An immunohistochemical quantitative analysis. J Oral Maxillofac Pathol 21:211–217. CrossRefPubMedPubMedCentralGoogle Scholar
  24. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-Relat Inflamm Nat 454:436–444. Google Scholar
  25. Miller KD et al (2016) Cancer treatment and survivorship statistics, 2016 CA: Cancer J Clin 66:271–289. Google Scholar
  26. Quaderi NA et al (1997) Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 17:285–291. CrossRefPubMedGoogle Scholar
  27. Robin NH et al (1995) Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2. Nat Genet 11:459–461. CrossRefPubMedGoogle Scholar
  28. Schweiger S, Schneider R (2003) The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome BioEssays: news and reviews in molecular. Cellular Dev Biol 25:356–366. Google Scholar
  29. Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017 CA: Cancer J Clin 67:7–30. Google Scholar
  30. Trockenbacher A et al (2001) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29:287–294. CrossRefPubMedGoogle Scholar
  31. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif 36:131–149CrossRefPubMedGoogle Scholar
  32. Watkins GR et al (2012) Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phosphorylation. J Biol Chem 287:24207–24215. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Winter J, Basilicata MF, Stemmler MP, Krauss S (2016) The MID1 protein is a central player during development and in disease. Frontiers Biosci 21:664–682CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Respiratory MedicineThe Second Affiliated Hospital of Jilin UniversityChangchunPeople’s Republic of China

Personalised recommendations